Sekar (Sek) Kathiresan — CEO
At Verve, we are focused on developing therapies that safely edit the adult human genome to treat heart attack. I come to Verve via learning cardiology at Harvard Medical School and deciphering the genomic basis for risk and resistance to heart attack at the Broad Institute and Massachusetts General Hospital.
Stackforce AI infers this person is a leader in Healthcare and Biotechnology with a focus on genomic medicine.
Location: Cambridge, Massachusetts, United States
Experience: 20 yrs 3 mos
Skills
- Healthcare
- Biotechnology
Career Highlights
- Pioneered genome editing therapies for heart disease.
- Extensive leadership experience in healthcare and biotechnology.
- Strong background in human genetics research.
Work Experience
Eli Lilly and Company
Senior Vice President (6 mos)
Relay Therapeutics
Member Board of Directors (3 yrs 9 mos)
Maze Therapeutics
Member Board of Directors (3 yrs 7 mos)
Massachusetts General Hospital
Honorary Physician, Department of Medicine (4 yrs 7 mos)
Director, Center for Genomic Medicine (3 yrs 2 mos)
Director, Preventive Cardiology (10 yrs)
Physician, Cardiology (24 yrs 3 mos)
Harvard Medical School
Lecturer in Medicine (4 yrs 7 mos)
Professor of Medicine (3 yrs 2 mos)
Verve Therapeutics
Chief Executive Officer, Founder (8 yrs 1 mo)
Broad Institute of MIT and Harvard
Co-Director, Program in Medical and Population Genetics (5 yrs 5 mos)
Principal Investigator (11 yrs 4 mos)
Education
Postdoctoral Research Fellow at Broad Institute
Postdoctoral Research Fellow at Framingham Heart Study
Chief Resident at Massachusetts General Hospital
Cardiovascular Medicine Fellowship Training Program at Massachusetts General Hospital
Internal Medicine Residency Program at Harvard Medical School - Massachusetts General Hospital
at Harvard Medical School
Bachelor of Arts - BA at University of Pennsylvania
at North Allegheny High School
